MYX 2470
Alternative Names: B7-H3-NMTi; Ifinatamab deruxtecan-N-myristoyltransferase inhibitor ADC - Myricx Pharma; MYX-2470Latest Information Update: 06 Nov 2023
At a glance
- Originator Myricx Pharma
- Class Antineoplastics; Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action Glycylpeptide N-tetradecanoyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours